Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma

被引:44
作者
Bastürk, B
Yavasçaoglu, I
Vuruskan, H
Göral, G
Oktay, B
Oral, HB [1 ]
机构
[1] Uludag Univ, Sch Med, Dept Microbiol & Infect Dis, Immunol Unit, TR-16059 Bursa, Turkey
[2] Uludag Univ, Sch Med, Dept Urol, TR-16059 Bursa, Turkey
关键词
cancer; cytokine; genotype; kidney;
D O I
10.1016/j.cyto.2004.10.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The major aim of this study was to investigate the association of the cytokine gene polymorphisms with the development of renal cell carcinoma (RCC). The study included 29 patients with RCC and 50 healthy controls. All genotyping (TNF-alpha, TGF-beta, IL-10, IL-6, IFN-gamma) experiments were performed using sequence-specific primers PCR (PCR-SSP). It was found that TNF-alpha -308 G/G and TGF-beta codon 10-25 T/T-G/C genotypes were significantly higher in frequency in the patients with RCC group compared with the healthy control group. Additionally, the frequency of TNF-alpha -308 G allele was significantly higher in the patients when compared to controls. On the other hand, the frequencies of TNF-alpha -308 G/A, IL-6 C/C and TGF-beta 1 codon 10-25 C/C-G/G genotypes were significantly lower in the cancer group compared with the healthy control group. However, after correction for multiple comparisons (Bonferroni), these results did not remain significant. Nevertheless, these findings suggest that the TNF-alpha -308 G/G and TGF-beta codon 10-25 T/T-G/C genotypes may be potential risk factors for RCC, whereas TNF-alpha -308 G/A, IL-6 C/ C and TGF-beta 1 codon 10-25 C/C-G/G genotypes may be possible protective factors. The number of the cases has to be increased to investigate the independency of these polymorphisms involved in the oncogenesis of RCC. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:41 / 45
页数:5
相关论文
共 30 条
[1]  
Angelo LS, 2002, CANCER RES, V62, P932
[2]  
AWAD RA, 2001, J HEART LUNG TRANSPL, V20, P265
[3]  
Barber MD, 1999, CLIN EXP IMMUNOL, V117, P425
[4]   THE BIOLOGY OF CACHECTIN/TNF - A PRIMARY MEDIATOR OF THE HOST RESPONSE [J].
BEUTLER, B ;
CERAMI, A .
ANNUAL REVIEW OF IMMUNOLOGY, 1989, 7 :625-655
[5]  
Bidwell JL, 1999, EUR J IMMUNOGENET, V26, P135
[6]   Cellular responses to interferon-gamma [J].
Boehm, U ;
Klamp, T ;
Groot, M ;
Howard, JC .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :749-795
[7]  
Cardillo MR, 1997, J EXP CLIN CANC RES, V16, P57
[8]  
Chouchane L, 1997, CANCER, V80, P1489, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1489::AID-CNCR17>3.0.CO
[9]  
2-1
[10]   Incidence in Izmir in 1993-1994: first results from Izmir Cancer Registry [J].
Fidaner, C ;
Eser, SY ;
Parkin, DM .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (01) :83-92